Exploiting amplification byproducts to enable colorimetric ctDNA detection via nanozyme inhibition
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118925 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Xiaohua Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Labora…. Hauptthemen laut MEDLINE: Colorimetry, Circulating Tumor DNA, Biosensing Techniques, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Sensitive circulating tumor DNA (ctDNA) analysis is increasingly important for mutation monitoring and molecular stratification in cancer management, yet most current approaches depend on complex signal transducers, fluorescent labels and sophisticated instrumentation. Here, we present an amplification byproduct-induced nanozyme suppression (ABINS) strategy that uses amplification byproducts as functional signals for colorimetric ctDNA detection. By coupling exponential amplification reaction (EXPAR) with Cu3(PO4)2 microflower nanozymes (Cu3(PO4)2 MFs), pyrophosphate (PPi) generated during amplification selectively inhibits the peroxidase-like activity of the nanozymes, resulting in a straightforward signal-off visual readout. This assay enables highly sensitive detection of KRAS G12D ctDNA at the femtomolar level and effectively discriminates target mutants from wild-type sequences. Furthermore, as a proof-of-concept, the sensing paradigm reliably discriminated KRAS-mutant patients from healthy donors in clinical plasma samples, showing good agreement with PCR-based analysis. The ABINS strategy provides a simple amplification-coupled and label-free colorimetric approach for mutation-associated ctDNA analysis, while broader validation in larger clinical cohorts and more representative ctDNA models will still be needed to further define its practical performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, Sichuan C…
- Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Respiratory and Critical Care Medicine, Center for High Altitude Medicine, L…
- Department of Respiratory and Critical Care Medicine, Center for High Altitude Medicine, Laboratory of Pulmonary Immunology and Inflammation, and Frontiers Science Center for Disease-Related Molecular Network, West Chin…
- Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, Sichuan Clinical Research Center for Laboratory Medicine, Institution of Medical and Engineering Integration for Molecular Diagnosis, West…
- Department of Physics, Faculty of Science, Islamic University of Madinah, Madinah, 42351, Saudi Arabia.
Förderung
- West China Hospital, Sichuan University
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Islamic University of Madinah
- Deanship of Scientific Research, King Khalid University
- Sichuan University
Zitieren
APA
Yuan, X., Liu, L., He, X., Tang, H., Zhang, L., Zhu, S., Cui, W., Luo, F., Shakir, I., Ying, B., Sun, X., & Zhou, J. (2026). Exploiting amplification byproducts to enable colorimetric ctDNA detection via nanozyme inhibition. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118925
Vancouver
Yuan X, Liu L, He X, Tang H, Zhang L, Zhu S, et al. Exploiting amplification byproducts to enable colorimetric ctDNA detection via nanozyme inhibition. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118925
BibTeX
@article{Yuan2026,
author = {Yuan, Xiaohua and Liu, Lianhua and He, Xun and Tang, Hong and Zhang, Limei and Zhu, Shuairu and Cui, Wanding and Luo, Fengming and Shakir, Imran and Ying, Binwu and Sun, Xuping and Zhou, Juan},
title = {Exploiting amplification byproducts to enable colorimetric ctDNA detection via nanozyme inhibition},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118925}
}
EUVIMED